michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you, Matt. We appreciate your questions.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. I'll let Dave take that. We have a few things on the books here.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, that's correct. I mean it wasn't a big change in outlook. It went from 20 to 40 down to flat to 20 down. So basically a 20 basis point improvement in expectation. And definitely, the trajectory of that would be better, earlier and more difficult later -- particularly the fourth quarter, I think our fourth quarter gross margin improvement was around 160 basis points last year, so significant. And that will be very surprising to get close to that number this year.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It is not, no. We have 64 days in Q2 and Q3 and 62 days in Q4, which is the same as we had last year. So, this was purely a Q1 issue. If you remember, last year was a leap year. So, I hate bringing this up. That's how the calendar works.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Brady, we're really happy with where we sit. There are no more markets on the chopping block, if you will. In Illinois, we have four branches there. We have about $160 million of deposits. We have $1 million of total loans. So those branches were established by Reliance Bank as a source of deposits, and they did a great job. We just don't have the infrastructure over there to support the Illinois side of St. Louis. We have 20 some odd branches in St. Louis that we're really focused on. So it made sense for us. So nothing else on the chopping block. We really like what we have, and we're committed to grow in all those markets.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think it all plays well, like, long-term ASIC strategy, which had a lot of performance and the more function and, at the same time, cost lower and low power consumption also. That's where the security is starting to expand, inside the data, inside a company, internal network. And also, the WAN side, SD-WAN 5G, we also see a lot of driving from that angle. So it's really starting to expand to the whole infrastructure instead of traditionally just secure Internet border. So that has a much bigger total addressable market. Sometimes we call secure-driven networking, but it's really a more expanded market and has a more strong security need.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, I think in terms of overall SiP business, last year, we had a 50% growth and so this year, I think the growth rate will start to -- will cut down a bit. But overall, I think the momentum is still there and we will continue to make the necessary investment to continue to grow our SiP business. In second quarter, I think the overall SiP business represents about 17% of our overall business from the Holding standpoint. And for EMS, about 40% and for assembly and test, is about 4% and all these ratios will grow in the second half.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
But, Gaston, anything else you want to add?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. It's a lot of infrastructure.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So that trend on private label versus brand, it's been kind of well under way for a period of time, Matt. So I would expect that to continue to be the case as consumers look for value, and even quality, quite frankly. I think the bigger trend that's going to be interesting for us to watch, and we view it as a tailwind here, is the fact that more people are going to be working from home for longer. Yes, the return to work will bring some office workers back in. But as you've seen, and it's been really well chronicled in the Journal and other news agencies here, is that there is an expectation that more people will be working from home. And again, 95% of what we do is food and beverage. And so if people are at home, there's a reasonable belief that you could have that we would see ongoing demand that would be different than what we saw before. Now on the other side of that, we can see some food service that may be not quite as strong. But as Steve mentioned, we're seeing a nice bounce-back there here in April, which was really our low watermark last year at this time. So I think that's how I'd have you think about it. Obviously, the retailers are going to have to do relative to store brand brands and -- versus consumer brands. But you've seen some of those consumer brands released their results already announced. They're going to take price because they're seeing things come out of them. So I think that's -- that will play out here over the next six to nine months.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think it's a run rate we can expect maybe with a little bit more growth in front of it, too. So, I mean that's what we aim for each year. And it's just some incremental pickup in terms of clients, price and margin. And then, really on the price and the margin side, it's really got a lot to do with all of it, frankly, as once again, it speaks to the high quality of the communities and the demand that's out there for affordable housing, and that's what we offer. So, I'd expect it to grow a little bit.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you. Just want to circle back to Uri. There are a lot of estimates that seem to be pretty varied and the largest vendor catastrophe modeling firms haven't provided their view yet. So I'm just wondering as you're thinking about your outlook for the year, it seems to be in the tight range, how you think about the industry loss size of this event? And if you could also just walk us through the mechanics to Uri reinsurance because I realize it's not linear. Or maybe I could follow-up on that question.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
What I would share with you that we've learned about the Credit Karma base is a big portion of their customers actually use an assisted method. And that is actually what is exciting to us. Now, because they have 110 million members, you can imagine they have a strong cross-section of folks in the US, whether Latinx, Self-Employed, those that are retail investors. So that cross-section is generally consistent with the customers we serve in TurboTax today. What's different is, we've got a good majority of those customers that in the prior year used an assisted method.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Robbie.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, I'll touch on maybe some broad macro on what we're seeing from an inflationary standpoint. We are seeing commodity prices way up. I mean, Mark talked about hydrocarbon crude prices being up. We're seeing chemical prices up. We're seeing supply shortages too. I am worried about supply chain issues. If we continue to see inflationary pressure, we may even think about mid-third quarter price increase. Typically, we do it late third quarter, early fourth quarter. We may have to do it earlier this year if we continue to see inflationary pressure. We are also worried about labor. We've got a quite a few vacancies today. Until the inflated unemployment runs out by September, we're going to struggle to get people in to run the service route for work. We are working hard to recruit. So certainly, worried about inflation and labor cost.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, I mean, it's a good question, Catherine, it's actually very difficult to pinpoint because it is extremely broad based, I mentioned that every geography across the globe is up almost equivalently, every end market is up, it's almost difficult to find a spot that we are concerned about.
So, it's really-everything we have, I can't really highlight one for you, like science is a strong, applied is kicking back in, food is strong, reproductive health is doing extremely well, immunodiagnostics I mentioned EUROIMMUN being up strong double digits. And everybody is above the 2019 levels and many of these markets are now on an average two-year stack comparison, at least mid-single digit, if not double digit growth comparing the 2019. So life science as an example is up 10% on average over the last few years.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, I mean, the cable gateway and cable modems segment of the retail Wi-Fi has always been pretty steady at some around 20% of the total market. And as you probably know, and there's just only one other major competitor, and because it's not easy. You have to get certified by all the cable operators in the U.S. We have a commanding market share.
And I mean, theoretically -- theoretically, we could get 100% market share in this segment. That means then we'll have a base of 20% market share of U.S. Wi-Fi. You know, so it's pretty lucrative.
Yeah.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Very little, unfortunately.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We haven't updated that yet. You know, I think there's a potential of certainly that these trends continue but at this point, we're going to stick with the 1.92 one.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi guys. Continuing to slide, you're looking at the same primary for both fibro and DPN, the change in NRS. So how important will the secondary endpoints be to better inform you on efficacy in the different patient populations? What are the key secondary endpoints? Just remind us of that? And also remind us why the 100-milligram dose in fibro, but not in DPN?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you, Patricia. I'd just like to thank everyone for their interest in Hayward. As you can see, our business is producing phenomenal operational and financial results. I'm very proud of the hard work and dedication from our team who continues to focus on providing the highest levels of service to our customers and allows Hayward to deliver such strong results.
We've continued to execute during the course of the year, including very strong Q3 results that were highlighted by net sales growth of 56% and nearly 90 basis points of margin expansion. We raised our annual guidance last quarter, and we're able to raise our top-line guidance again this quarter while managing through an increasingly challenging supply chain and inflationary environment. We're very well-positioned to continue to generate growth for all stakeholders in 2021 and the years ahead. Please reach out to our team if you have any follow-up questions, and we look forward to talking to you again soon.
Thank you.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We are.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, this is Kevin, I'll take that one too. Their focus will initially be on insulin using patients who have reimbursement for the technology. The non-insulin users will in fact tag along as they become aware and there are situations where some of these patients who have coverage. On the type 2 non-intensive patient, we've been very clear from the beginning that we're going to go about that in this market four different ways, through programs, payers, clinicians and then directly to patients. And over the course of 2021, you will see those four initiatives unfold as we gather more data and launch more initiatives. And so awareness will grow, as Quentin said earlier and Steve, a very reasonable number of our leads from the Super Bowl ad have been tied to non-intensive patients. Whether we can serve them or not with reimbursement today remains to be seen, but we certainly have a database of these names and people we can call on as soon as we have the product offering, we want to get in that space ready.
So I think we're preparing and getting ready for that. More importantly though, as we make these clinicians aware, they can look for cases where they can make it available to their patients, they can look at situations where somebody can appeal for coverage if they have type 2 diabetes and out of control and those appeals have been successful. So we're looking forward to going there and -- but these guys will focus on our core markets and where we play with reimbursement first and foremost.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Operator, are we still there?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So what we're seeing is the West has seen some positivity and really the Gulf. And they're the ones that are starting to have been reopened and are reopening more. When we saw the start and stop is we have a lot of operations in the Michigan corridor and they've been a hotspot. And so, that was a challenge in the first quarter.
But they're getting things under control. And we anticipate that that to improve here overall. And then, internationally, Canada continues to struggle. They're not -- they don't have the same vaccination rates that we do here.
And I think Ontario just walk back down or the province of Ontario. And so, they've been struggling there. But the underlying business still seems to be gaining traction and positive momentum even though they're going through some starts and stops.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, I'll take the first part of that. I don't think we've noticed any real change in the referral patterns from our -- the Med-Surg hospitals. We have had very steady referrals from the ERs. And that really started a year ago in June after the height of the pandemic and the stay at home. And I think in June, we started to see them referring again. We've been very focused here in the company on responsiveness because we know it's important to the ERs that their patients get to the right place and that they get care and they get it in a timely way. So I think that that's been helpful to our ER referrals. I think that certainly, they've been very stable and steady. If I think about the joint ventures and just the impact of COVID and certainly, this latest resurgence, we've had, I think, a very active pipeline of partnerships. And I do think that they have not actually slowed but they've actually accelerated. And I said before, I was a little surprised by that. But I do think that they see that they want to focus on other service areas within the MedSurg systems, and we do have a strong track record. So I think they are reaching out. Most of the times, it's a competitive process, and we're pleased that they're choosing Acadia. We hope actually to be making a few announcements coming up in the fourth quarter. And these are going to be strong partnerships that again we're proud of. So I do think those are going to continue, and if nothing else, probably accelerate as we go forward.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, I think as a rule of thumb NT$1 of investment in packaging we can generate about NT$1.20 of revenue on any -- and for tests NT$1 of investment can generate about NT$0.50 of revenue.
So, from a blended point perspective, I think NT$1 of -- what we're seeing is in terms of assembly and test, NT$1 of investment should generate NT$1 of revenue for us -- a blended revenue for us to make it an economically viable investment. I think the -- from a different angle to look at TSMC's investment into back-end, that's totally different scenario.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It's just a couple of million pounds, Greg. So there's still a going concern in terms of some legacy contracts, so it's just the intercompany management of that.

    Prediction (one of UP, DOWN, SAME): UP